Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Chronomodulated irinotecan, oxaliplatin, and leucovorin-modulated 5-Fluorouracil as ambulatory salvage therapy in patients with irinotecan- and oxaliplatin-resistant metastatic colorectal cancer.
Gholam D, Giacchetti S, Brézault-Bonnet C, Bouchahda M, Hauteville D, Adam R, Ducot B, Ghémard O, Kustlinger F, Jasmin C, Lévi F. Gholam D, et al. Oncologist. 2006 Nov-Dec;11(10):1072-80. doi: 10.1634/theoncologist.11-10-1072. Oncologist. 2006. PMID: 17110626 Free article. Clinical Trial.
Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemia.
Letestu R, Dahmani A, Boubaya M, Baseggio L, Campos L, Chatelain B, Debliquis A, Drénou B, Jacob MC, Legac E, Le Garff-Tavernier M, Lhoumeau AC, Quiney C, Robillard N, Ticchioni M, Aanei C, Katsahian S, Delepine R, Vaudaux S, Rouillé V, Béné MC, Dartigeas C, Van Den Neste E, Leprêtre S, Feugier P, Cartron G, Leblond V, Lévy V, Cymbalista F; French Innovative Leukemia Organization (FILO). Letestu R, et al. Leukemia. 2021 Jun;35(6):1597-1609. doi: 10.1038/s41375-020-01009-z. Epub 2020 Sep 15. Leukemia. 2021. PMID: 32934355
Combined paclitaxel and cetuximab achieved a major response on the skin metastases of a patient with epidermal growth factor receptor-positive, estrogen receptor-negative, progesterone receptor-negative and human epidermal growth factor receptor-2-negative (triple-negative) breast cancer.
Gholam D, Chebib A, Hauteville D, Bralet MP, Jasmin C. Gholam D, et al. Anticancer Drugs. 2007 Aug;18(7):835-7. doi: 10.1097/CAD.0b013e3280adc8e0. Anticancer Drugs. 2007. PMID: 17581308
Primary breast lymphoma.
Gholam D, Bibeau F, El Weshi A, Bosq J, Ribrag V. Gholam D, et al. Leuk Lymphoma. 2003 Jul;44(7):1173-8. doi: 10.1080/1042819031000079195. Leuk Lymphoma. 2003. PMID: 12916870 Review.
[Primary breast lymphoma during pregnancy: a case report].
Montilla F, Grolier F, Gholam D, Diquelou JY, Amar P, Boyer S, Karoubi R. Montilla F, et al. Among authors: gholam d. Gynecol Obstet Fertil. 2007 Nov;35(11):1129-32. doi: 10.1016/j.gyobfe.2007.08.023. Gynecol Obstet Fertil. 2007. PMID: 18198499 French.
16 results